Cargando…

Development of molecular confirmation tools for swift and easy rabies diagnostics

BACKGROUND: As rabies still represents a major public threat with tens of thousands of deaths per year, particularly in developing countries, adequate surveillance based on rapid and reliable rabies diagnosis for both humans and animals is essential. Rabies diagnosis relies on highly sensitive and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlottau, Kore, Freuling, Conrad M., Müller, Thomas, Beer, Martin, Hoffmann, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610444/
https://www.ncbi.nlm.nih.gov/pubmed/28938887
http://dx.doi.org/10.1186/s12985-017-0853-y
_version_ 1783265780078477312
author Schlottau, Kore
Freuling, Conrad M.
Müller, Thomas
Beer, Martin
Hoffmann, Bernd
author_facet Schlottau, Kore
Freuling, Conrad M.
Müller, Thomas
Beer, Martin
Hoffmann, Bernd
author_sort Schlottau, Kore
collection PubMed
description BACKGROUND: As rabies still represents a major public threat with tens of thousands of deaths per year, particularly in developing countries, adequate surveillance based on rapid and reliable rabies diagnosis for both humans and animals is essential. Rabies diagnosis relies on highly sensitive and specific laboratory tests for detection of viral antigens. Among those tests, at present the immunofluorescence antibody test is the “gold standard test” for rabies diagnosis, followed by virus isolation in either mice or cell culture. Because of the advantages of molecular assays in terms of sensitivity and applicability their approval as confirmatory diagnostic test by international organizations (OIE, WHO) is envisaged. Therefore, the objective was to develop and validate novel molecular assays and RNA extraction methods for rabies that reduce the turnaround time but remain highly sensitive and specific. METHODS: Here, novel assays, i.e. HighSpeed RT-qPCR and isothermal recombinase polymerase amplification (RPA) were designed and tested. Furthermore, three magnetic bead-based rapid extraction methods for manual or automated extraction were validated and combined with the new downstream assays. RESULTS: While the conventional column based RNA extraction method showed the highest intra-run variations, all magnetic bead-based rapid extraction methods delivered nearly comparable sensitivity and efficiency of RNA recovery. All newly developed molecular tests were able to detect different rabies virus strains in a markedly reduced timeframe in comparison to the standard diagnostic assays. The observed detection limit for the HighSpeed RT-qPCR was 10 genome copies per reaction, and 1000 genome copies per reaction for the RPA assay. CONCLUSION: Magnetic bead-based rapid RNA extraction methods are highly sensitive and show a high level of reproducibility and therefore, are particularly suitable for molecular diagnostic assays including rabies. In addition, with a detection limit of 10 genome copies per reaction, the HighSpeed RT-qPCR is suitable for rapid ante mortem rabies diagnosis in humans as well as confirmatory test in integrated bite management and subsequent post-exposure prophylaxis.
format Online
Article
Text
id pubmed-5610444
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56104442017-10-10 Development of molecular confirmation tools for swift and easy rabies diagnostics Schlottau, Kore Freuling, Conrad M. Müller, Thomas Beer, Martin Hoffmann, Bernd Virol J Research BACKGROUND: As rabies still represents a major public threat with tens of thousands of deaths per year, particularly in developing countries, adequate surveillance based on rapid and reliable rabies diagnosis for both humans and animals is essential. Rabies diagnosis relies on highly sensitive and specific laboratory tests for detection of viral antigens. Among those tests, at present the immunofluorescence antibody test is the “gold standard test” for rabies diagnosis, followed by virus isolation in either mice or cell culture. Because of the advantages of molecular assays in terms of sensitivity and applicability their approval as confirmatory diagnostic test by international organizations (OIE, WHO) is envisaged. Therefore, the objective was to develop and validate novel molecular assays and RNA extraction methods for rabies that reduce the turnaround time but remain highly sensitive and specific. METHODS: Here, novel assays, i.e. HighSpeed RT-qPCR and isothermal recombinase polymerase amplification (RPA) were designed and tested. Furthermore, three magnetic bead-based rapid extraction methods for manual or automated extraction were validated and combined with the new downstream assays. RESULTS: While the conventional column based RNA extraction method showed the highest intra-run variations, all magnetic bead-based rapid extraction methods delivered nearly comparable sensitivity and efficiency of RNA recovery. All newly developed molecular tests were able to detect different rabies virus strains in a markedly reduced timeframe in comparison to the standard diagnostic assays. The observed detection limit for the HighSpeed RT-qPCR was 10 genome copies per reaction, and 1000 genome copies per reaction for the RPA assay. CONCLUSION: Magnetic bead-based rapid RNA extraction methods are highly sensitive and show a high level of reproducibility and therefore, are particularly suitable for molecular diagnostic assays including rabies. In addition, with a detection limit of 10 genome copies per reaction, the HighSpeed RT-qPCR is suitable for rapid ante mortem rabies diagnosis in humans as well as confirmatory test in integrated bite management and subsequent post-exposure prophylaxis. BioMed Central 2017-09-22 /pmc/articles/PMC5610444/ /pubmed/28938887 http://dx.doi.org/10.1186/s12985-017-0853-y Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Schlottau, Kore
Freuling, Conrad M.
Müller, Thomas
Beer, Martin
Hoffmann, Bernd
Development of molecular confirmation tools for swift and easy rabies diagnostics
title Development of molecular confirmation tools for swift and easy rabies diagnostics
title_full Development of molecular confirmation tools for swift and easy rabies diagnostics
title_fullStr Development of molecular confirmation tools for swift and easy rabies diagnostics
title_full_unstemmed Development of molecular confirmation tools for swift and easy rabies diagnostics
title_short Development of molecular confirmation tools for swift and easy rabies diagnostics
title_sort development of molecular confirmation tools for swift and easy rabies diagnostics
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610444/
https://www.ncbi.nlm.nih.gov/pubmed/28938887
http://dx.doi.org/10.1186/s12985-017-0853-y
work_keys_str_mv AT schlottaukore developmentofmolecularconfirmationtoolsforswiftandeasyrabiesdiagnostics
AT freulingconradm developmentofmolecularconfirmationtoolsforswiftandeasyrabiesdiagnostics
AT mullerthomas developmentofmolecularconfirmationtoolsforswiftandeasyrabiesdiagnostics
AT beermartin developmentofmolecularconfirmationtoolsforswiftandeasyrabiesdiagnostics
AT hoffmannbernd developmentofmolecularconfirmationtoolsforswiftandeasyrabiesdiagnostics